分子影像学杂志2024，Vol.47Issue(6)：598-604,7.DOI:10.12122/j.issn.1674-4500.2024.06.07
BRAFV600E基因联合增强CT的列线图模型对TI-RADS 3类及以上甲状腺结节良恶性鉴别诊断的价值
Value of a column-line diagram model incorporating BRAFV600E gene and enhanced CT in the differential diagnosis of thyroid nodules categorized as TI-RADS 3 and above
摘要
Abstract
Objective To construct a thyroid imaging reporting and data system (TI-RADS) benign-malignant prediction model for thyroid nodules categorized as TI-RADS 3 and above, incorporating both BRAFV600E gene mutation status and enhanced CT features, and assess its diagnostic efficacy. Methods A retrospective analysis of data from 251 patients with TI-RADS 3 and above thyroid nodules admitted to Chaohu Hospital of Anhui Medical University from October 2022 to February 2024 were conducted. Ultrasound-guided fine-needle aspiration cytology and postoperative pathology served as the "gold standard", with 177 nodules classified as benign and 74 as malignant. The LASSO regression method was employed for variable and predictor selection, leading to the establishment of a prediction model. Results LASSO regression identified four variables for inclusion in the prediction model: age, BRAFV600E gene mutation status, presence of blurred borders on enhanced CT, and discontinuity of the nodule envelope. A prediction model for BRAFV600E gene mutation status in enhanced CT was developed based on these variables and subsequently validated. The AUC for the combined prediction model was 0.816, surpassing that of the enhanced CT prediction model alone (AUC=0.755) with statistical significance (P< 0.05). The joint prediction model demonstrated a sensitivity of 88.7％, specificity of 63.5％, and accuracy of 81.7％, with a Hosmer-Lemeshow fit test yielding P=0.4564. The net reclassification index compared to the enhanced CT prediction model alone was 0.308 (0.151-0.465) (P<0.001), and the integrated discrimination improvement index was 0.114 (0.060-0.167) (P<0.001). Decision curve analysis and calibration curves confirmed the high predictive performance of the combined prediction model. Conclusion The column-line diagram model combining BRAFV600E gene mutation status with enhanced CT features demonstrates significant diagnostic value in distinguishing between benign and malignant nodules categorized as TI-RADS 3 and above.关键词
甲状腺结节/BRAFV600E基因/增强CT/列线图模型/验证/净重新分类指数Key words
thyroid nodule/BRAFV600E gene/enhanced CT/column line drawing model/validation/net reclassification index引用本文复制引用
余晨帆,窦家庆..BRAFV600E基因联合增强CT的列线图模型对TI-RADS 3类及以上甲状腺结节良恶性鉴别诊断的价值[J].分子影像学杂志,2024,47(6):598-604,7.基金项目
安徽高校自然科学研究项目(KJ2021ZD0033) （KJ2021ZD0033）
